← Open Payments lookup

RICHARD SCHOLLAERT: Open Payments

NPI 1962428292 · AMBRIDGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,371 in 117 payments from 21 companies in 2025. Trend: 2023 $1,751 · 2024 $1,907 · 2025 $2,371

Food & beverage: $2,371
CompanyPaymentsAmount
Novo Nordisk Inc25$578
AstraZeneca Pharmaceuticals LP18$405
GlaxoSmithKline, LLC.14$239
Boehringer Ingelheim Pharmaceuticals, Inc.10$158
Amgen Inc.7$130
Otsuka America Pharmaceutical, Inc.5$129
Lilly USA, LLC6$120
E.R. Squibb & Sons, L.L.C.5$96
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$88
PFIZER INC.4$81

Products named: Ozempic, TRELEGY ELLIPTA, BREZTRI, Wegovy, AIRSUPRA, JARDIANCE, REXULTI, MOUNJARO.

Industry payments across PA — which companies pay providers there.